Have questions? Visit https://www.reddit.com/r/SNPedia

rs6698181

From SNPedia

Orientationplus
Stabilizedplus
Make rs6698181(C;C)
Make rs6698181(C;T)
Make rs6698181(T;T)
ReferenceGRCh38 38.1/141
Chromosome1
Position88677622
GenePKN2-AS1
is asnp
is mentioned by
dbSNPrs6698181
ebirs6698181
HLIrs6698181
Exacrs6698181
Varsomers6698181
Maprs6698181
PheGenIrs6698181
hapmaprs6698181
1000 genomesrs6698181
hgdprs6698181
ensemblrs6698181
gopubmedrs6698181
geneviewrs6698181
scholarrs6698181
googlers6698181
pharmgkbrs6698181
gwascentralrs6698181
openSNPrs6698181
23andMers6698181
23andMe allrs6698181
SNP Nexus

SNPshotrs6698181
SNPdbers6698181
MSV3drs6698181
GWAS Ctlgrs6698181
GMAF0.2975
Max Magnitude
? (C;C) (C;T) (T;T) 28
Rs6698181
PubMed [PMID 17463246]
Affy Probeset SNP_A-2129780
Affy Orientation same
On GW 5.0 1
Alleles A/B C/T
Ancestral C
Population NEU
Allele T
Case Freq.
Control Freq. 0.29
Odds Ratio Het
Odds Ratio Hom
Odds Ratio All 1.11
Disease Type II Diabetes (T2D)


rs6698181 increases susceptibility to Type II Diabetes 1.11 times for carriers of the T allele [PMID 17463246]



[PMID 18443202OA-icon.png] Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.


[PMID 21084393OA-icon.png] Type 2 diabetes (T2D) associated polymorphisms regulate expression of adjacent transcripts in transformed lymphocytes, adipose, and muscle from Caucasian and African-American subjects.


GET Evidence
rs6698181
aa_change
aa_change_short
impact pharmacogenetic
qualified_impact Insufficiently evaluated pharmacogenetic
overall_frequency 0.210938
summary